NeuroScientific Biopharmaceuticals Ltd ABN: 13 102 832 995 Level 4, 216 St Georges Terrace, Perth WA 6000 https://neuroscientific.com +61 8 6268 2641 8 September 2026 Dear Shareholders, ANNUAL GENERAL MEETING The shareholder meeting is scheduled to be held on Thursday, 15...
Letter to Shareholders & Proxy Form
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Miro Sciences
- Resignation and Appointment of Auditor
- Appendix 4G & Corporate Governance Statement
- 2026 Annual Report & Appendix 4E
- Pre-IND Meeting with US FDA Scheduled
Later from Miro Sciences
- Notice of Annual General Meeting & Proxy Form
- Leading CRO Appointed for Phase 2 Crohn's Trial
- US FDA Provides Positive Feedback on Planned Phase 2 Trial
- Results of Annual General Meeting
- Appointment of CFO
